Treatment of factor VIII inhibitors.
Kasper
C K
CK
D000818:Animals; D000941:Antigens / Q000276:immunology* / Q000627:therapeutic use; D001323:Autoantibodies / Q000276:immunology*; D001327:Autoimmune Diseases / Q000276:immunology; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D005164:Factor IX / Q000627:therapeutic use; D005169:Factor VIII / Q000276:immunology* / Q000627:therapeutic use; D005260:Female; D006467:Hemophilia A / Q000276:immunology; D006474:Hemorrhagic Disorders / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007518:Isoantibodies / Q000276:immunology*; D010956:Plasmapheresis; D049590:Postpartum Period / Q000276:immunology; D011247:Pregnancy; D013552:Swine / Q000276:immunology
D000941:Antigens; D001323:Autoantibodies; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D007518:Isoantibodies; D005169:Factor VIII; D005164:Factor IX; D003894:Deamino Arginine Vasopressin